The placental-umbilical unit in sickle cell disease pregnancy: A model for studying in vivo functional adjustments to hypoxia in humans

Human Pathology

Volumn 35, Issue 11, 2004, Pages 1353-1359

  Trampont, Paul ^a,f   Roudier, Martine ^b,g   Andrea, Anne Marie ^b   Nomal, Nelly ^b   Mignot, Therese Marie ^c   Leborgne Samuel, Yanick ^d   Ravion, Sylvie ^a   Clayton, John ^a   Mary, Didier ^a   Elion, Jacques ^e   Decastel, Monique ^a  

^a INSERM   (France)

^b Service d'Anatomie Pathologique   (France)

^c INSERM U 361 Maternite Baudelocque ^*  (France)

^d Section of Radiology   (France)

^e HÔPITAL ROBERT DEBRÉ   (France)

^f UNIVERSITY OF VIRGINIA   (United States)

^g Genito Urinary Cancer Res Lab   (United States)

Author keywords

DAB; diaminobenzidine; EC; ELISA; endothelial cell; endothelial nitric oxide synthase; eNOS; enzyme linked immunosorbent assay; Hb SC; Hb SS; hypoxia; PECAM 1 VEGF pathway; sickle cell disease; sickle cell hemoglobin C disease; tolerance

Indexed keywords

CD31 ANTIGEN; INTERLEUKIN 6; INTERLEUKIN 8; PADGEM PROTEIN; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRIN DEPOSITION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; MATERNAL BLOOD; PATHOPHYSIOLOGY; PLACENTA; PREGNANCY; PROTEIN EXPRESSION; SICKLE CELL ANEMIA; SYNCYTIUM; UMBILICUS;

ADAPTATION, PHYSIOLOGICAL; ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; ANOXIA; ANTIGENS, CD31; BIOLOGICAL MARKERS; ENDOTHELIUM, VASCULAR; FEMALE; FETAL BLOOD; HOMEOSTASIS; HUMANS; MODELS, BIOLOGICAL; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; UMBILICAL CORD; UMBILICAL VEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 10044220530     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2004.07.003     Document Type: Article

References (36)

1. Kaul D.K., Fabry M.E., Costantini F., et al. In vivo demonstration of red cell-endothelial interaction, sickling and altered microvascular response to oxygen in the sickling transgenic mouse. J Clin Invest. 96:1995;2845-2853
2. Setty B.N., Stuart M.J. Vascular cell adhesion molecule-1 is involved in mediating hypoxia-induced sickle red blood cell adherence to endothelium Potential role in sickle cell disease. Blood. 88:1996;2311-2320
3. De Franceschi L., Brugnara C., Rouyer-Fessard P., et al. Formation of dense erythrocytes in SAD mice exposed to chronic hypoxia Evaluation of different therapeutic regimens and of a combination of oral clotrimazole and magnesium therapies. Blood. 94:1999;4307-4313
4. Osei S.Y., Ahima R.S., Fabry M.E., et al. Immunohistochemical localization of hepatic nitric oxide synthase in normal and transgenic sickle cell mice The effect of hypoxia. Blood. 88:2000;3583-3588
5. Iyamu E.W., Turner E.A., Asakura T. Niprisan (Nixo) improves the survival rates of transgenic sickle cell mice under acute severe hypoxic conditions. Br J Haematol. 122:2003;1001-1008
6. Pauling I., Itano H., Singer S.J. Sickle cell anemia A molecular disease. Science. 110:1949;543-548
7. Francis R.B., Johnson C.S. Vascular occlusion in sickle cell disease Current concepts and unanswered questions. Blood. 77:1991;1405-1410
8. Hebbel R.P., Boogaerts M.A., Eaton J.W., et al. Erythrocyte adherence to endothelium in sickle cell anemia A possible determinant of disease severity. N Engl J Med. 302:1980;992-995
9. Kaul D.K., Hebbel R.P. Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice. J Clin Invest. 106:2000;411-420
10. Koshy M. Sickle cell disease and pregnancy. Blood Rev. 9:1995;157-164
11. Leborgne-Samuel Y., Janky E., Venditelli F., et al. Drépanocytose et grossesse Revue de 68 cas en Guadeloupe. J Gynecol Obstet Biol Reprod. 29:2000;86-93
12. Gersell D.J. Selected vascular lesions of the placenta. Gynecol Pathol. 15:1995;611-629
13. Pantanowitz L., Schwartz R., Balogh K. The placenta in sickle cell disease. Arch Pathol Lab Med. 124:2000;1565-1567
14. Alexandre L., Keclard L., Romana M., et al. Efficiency of prenatal counselling for sickle cell disease in Guadeloupe. Gen Counsel. 8:1997;25-33
15. Decastel M., Leborgne-Samuel Y., Alexandre L., et al. Morphological features of the human umbilical vein in normal, sickle cell trait, and sickle cell disease pregnancies. Hum Pathol. 30:1999;13-20
16. Granger J.P., Alexander B.T., Llinas M.T., et al. Pathophysiology of preeclampsia Linking placental ischemia/hypoxia with microvascular dysfunction. Microcirculation. 9:2002;147-160
17. Redman C.W., Sacks G.P., Sargent I.L. Preeclampsia an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol. 180:1999;499-506
18. Matkowsky K.A., Schonfeld D., Benya R.V. Quantitative immunohistochemistry by measuring cumulative signal strength using commercially available Photoshop and Matlab. J Histochem Cytochem. 48:2000;303-311
19. Amin M.R., Kurosaki M., Watanabe T., et al. A comparative study of MIB-1 staining indices of gliomas measured by NIH image analysis program and conventional manual cell counting method. Neurol Res. 22:2000;495-500
20. Sargent I.L., Germain S.J., Sacks G.P., et al. Trophoblast deportation and the maternal inflammatory response in preeclampsia. J Reprod Immunol. 59:2003;153-160
21. Newman P.J. The biology of PECAM-1. J Clin Invest. 99:1997;3-8
22. Denis C.V. Molecular and cellular biology of von Willebrand factor. Int J Hematol. 75:2002;3-8
23. Imhof B.A., Dunon D. Leukocyte migration and adhesion. Adv Immunol. 58:1995;345-416
24. Müller A.M., Cronen C., Müller K.M., et al. Comparative analysis of the reactivity of human umbilical vein endothelial cell in organ and monolayer culture. Pathobiology. 67:1999;99-107
25. Pugnaloni M., Salvolini E., Lucarini G., et al. The human umbilical vein in normal, hypertensive and diabetic pregnancies Immunomorphological and ultrastructural evidence. Gynecol Obstet Inv. 39:1995;239-246
26. Hermes-Lima M., Zenteno-Savin T. Animal response to drastic changes in oxygen availability and physiological oxidative stress. Comp Biochem Physiol. 133:2002;537-556
27. Goerge T., Niemeyer A., Rogge P., et al. Secretion pores in human endothelial cells during acute hypoxia. J Membr Biol. 187:2002;203-221
28. Utgaard J.O., Jahnsen F.L., Brandzaeg P., et al. Rapid secretion of prestored interleukin 8 from Weibel-Palade bodies of microvascular endothelial cells. J Exp Med. 188:1998;1751-1756
29. Hartwell D.W., Mayadas T.N., Berger G., et al. Role of P-selectin cytoplasmic domain in granular targeting in vivo and in early inflammatory responses. J Cell Biol. 143:1998;1129-1141
30. Mildenberger E., Siegel G., Versmold H.T. Oxygen-dependent regulation of membrane potential and vascular tone of human umbilical vein. Am J Obstet Gynecol. 18:1999;696-700
31. Dikranian K., Trosheva M., Nikolov S., et al. Nitric oxide synthase (NOS) in the human umbilical cord vessels An immunohistochemical study. Acta Histochem. 96:1994;145-153
32. Phelan M.W., Faller D.V. Hypoxia decreases constitutive nitric oxide synthase transcript and protein in cultured endothelial cells. J Cell Physiol. 167:1996;469-476
33. Ni Y., May V., Braas K., et al. Pregnancy augments uteroplacental vascular endothelial growth factor gene expression and vasodilator effect. Am J Physiol. 273:1997;H938-H944
34. Connolly D.T. Vascular permeability factor A unique regulator of blood vessel functions. J Cell Biochem. 47:1991;219-223
35. Solovey A., Gui L., Ramakrishnan S., et al. Sickle cell anaemia as a possible state of enhanced anti-apoptotic tone Survival effect of vascular endothelial growth factor on circulating and unanchored endothelial cells. Blood. 93:1999;3824-3830
36. Evans P.C., Taylor E.R., Kilshaw P.J. Signaling through CD31 protects endothelial cells from apoptosis. Transplantation. 71:2001;457-460